moxifloxacin has been researched along with ramatroban in 1 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (ramatroban) | Trials (ramatroban) | Recent Studies (post-2010) (ramatroban) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 142 | 10 | 28 |
| Protein | Taxonomy | moxifloxacin (IC50) | ramatroban (IC50) |
|---|---|---|---|
| Thromboxane A2 receptor | Homo sapiens (human) | 0.0107 | |
| Acyl-CoA:cholesterol acyltransferase | Oryctolagus cuniculus (rabbit) | 0.311 | |
| Neuronal acetylcholine receptor subunit alpha-6 | Mus musculus (house mouse) | 0.311 | |
| Prostaglandin D2 receptor 2 | Homo sapiens (human) | 0.2289 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
1 other study(ies) available for moxifloxacin and ramatroban
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |